Literature DB >> 6630528

Nature and quantity of fuels consumed in patients with alcoholic cirrhosis.

O E Owen, V E Trapp, G A Reichard, M A Mozzoli, J Moctezuma, P Paul, C L Skutches, G Boden.   

Abstract

Although alcoholism is a leading cause of morbidity and mortality of middle-aged Americans, there are no data available pertaining to the consequences of Laennec's cirrhosis on total body energy requirements or mechanisms for maintaining fuel homeostasis in this patient population. Therefore, we simultaneously used the techniques of indirect calorimetry and tracer analyses of [14C]palmitate to measure the nature and quantity of fuels oxidized by patients with biopsy-proven alcoholic cirrhosis and compared the results with values obtained from health volunteers. Cirrhotic patients were studied after an overnight fast (10-12 h). Normal volunteers were studied after an overnight fast (12 h) or after a longer period of starvation (36-72 h). Total basal metabolic requirements were similar in overnight fasted cirrhotic patients (1.05 +/- 0.06 kcal/min per 1.73 m2), overnight fasted normal subjects (1.00 +/- 0.05 kcal/min per 1.73 m2), and 36-72-h fasted normal volunteers (1.10 +/- 0.06 kcal/min per 1.73 m2). Indirect calorimetry revealed that in cirrhotic patients the percentages of total calories derived from fat (69 +/- 3%), carbohydrate (13 +/- 2%), and protein (17 +/- 4%) were comparable to those found in 36-72-h fasted subjects, but were clearly different from those of overnight fasted normal individuals who derived 40 +/- 6, 39 +/- 4, and 21 +/- 2% from fat, carbohydrate, and protein, respectively. These data are strikingly similar to data obtained through tracer analyses of [14C]palmitate, which showed that in overnight fasted patients with alcoholic cirrhosis, 63 +/- 4% of their total CO2 production was derived from oxidation of 287 +/- 28 mumol free fatty acids (FFA)/min per 1.73 m2. In contrast, normal overnight fasted humans derived 34 +/- 6% of their total CO2 production from the oxidation of 147 +/- 25 mumol FFA/min per 1.73 m2. On the other hand, values obtained from the normal volunteers fasted 36-72 h were similar to the overnight fasted cirrhotic patients. These results show that after an overnight fast the caloric requirements of patients with alcoholic cirrhosis are normal, but the nature of fuels oxidized are similar to normal humans undergoing 2-3 d of total starvation. Thus, patients with alcoholic cirrhosis develop the catabolic state of starvation more rapidly than do normal humans. This disturbed but compensated pattern for maintaining fuel homeostasis may be partly responsible for the cachexia observed in some patients with alcoholic cirrhosis. This study also showed remarkably good agreement between the results obtained with indirect calorimetry and those obtained with 14C tracer analyses.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6630528      PMCID: PMC370471          DOI: 10.1172/JCI111142

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

1.  TURNOVER RATE AND OXIDATION OF DIFFERENT FREE FATTY ACIDS IN MAN DURING EXERCISE.

Authors:  R J HAVEL; L A CARLSON; L G EKELUND; A HOLMGREN
Journal:  J Appl Physiol       Date:  1964-07       Impact factor: 3.531

2.  Glucose tolerance and diabetes in chronic liver disease.

Authors:  C Megyesi; E Samols; V Marks
Journal:  Lancet       Date:  1967-11-18       Impact factor: 79.321

3.  Metabolic changes in active chronic hepatitis.

Authors:  K G Alberti; C O Record; D H Williamson; R Wright
Journal:  Clin Sci       Date:  1972-05       Impact factor: 6.124

4.  Oxidation of plasma FFA in lean and obese humans.

Authors:  B Issekutz; P Paul; H I Miller; W M Bortz
Journal:  Metabolism       Date:  1968-01       Impact factor: 8.694

5.  Alcohol and dietary factors in cirrhosis. An epidemiological study of 304 alcoholic patients.

Authors:  A J Patek; I G Toth; M G Saunders; G A Castro; J J Engel
Journal:  Arch Intern Med       Date:  1975-08

6.  On the maximal possible rate of ketogenesis.

Authors:  J P Flatt
Journal:  Diabetes       Date:  1972-01       Impact factor: 9.461

7.  Turnover rate of plasma FFA in humans and in dogs.

Authors:  B Issekutz; W M Bortz; H I Miller; P Paul
Journal:  Metabolism       Date:  1967-11       Impact factor: 8.694

8.  Hepatic, gut, and renal substrate flux rates in patients with hepatic cirrhosis.

Authors:  O E Owen; F A Reichle; M A Mozzoli; T Kreulen; M S Patel; I B Elfenbein; M Golsorkhi; K H Chang; N S Rao; H S Sue; G Boden
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

9.  Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis.

Authors:  D G Bichet; V J Van Putten; R W Schrier
Journal:  N Engl J Med       Date:  1982-12-16       Impact factor: 91.245

10.  Hepatic ketogenesis and gluconeogenesis in humans.

Authors:  A J Garber; P H Menzel; G Boden; O E Owen
Journal:  J Clin Invest       Date:  1974-10       Impact factor: 14.808

View more
  43 in total

1.  Predictive factors for platelet count after laparoscopic splenectomy in cirrhotic patients.

Authors:  Daisuke Yoshida; Yoshihiro Nagao; Morimasa Tomikawa; Hirofumi Kawanaka; Tomohiko Akahoshi; Nao Kinjo; Hideo Uehara; Naotaka Hashimoto; Makoto Hashizume; Yoshihiko Maehara
Journal:  Hepatol Int       Date:  2011-09-30       Impact factor: 6.047

2.  Hepatobiliary quiz-7 (2013).

Authors:  Swastik Agrawal; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2013-09

Review 3.  Changes in nutritional status after liver transplantation.

Authors:  Michela Giusto; Barbara Lattanzi; Vincenza Di Gregorio; Valerio Giannelli; Cristina Lucidi; Manuela Merli
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

4.  Nonalcoholic fatty liver is a risk factor for postprandial hyperglycemia, but not for impaired fasting glucose.

Authors:  Tomoko Shiga; Yuriko Moriyoshi; Hikaru Nagahara; Keiko Shiratori
Journal:  J Gastroenterol       Date:  2009-05-02       Impact factor: 7.527

Review 5.  Nutrition and growth in patients with chronic liver disease.

Authors:  D A Kelly
Journal:  Indian J Pediatr       Date:  1995 Sep-Oct       Impact factor: 1.967

6.  ESPEN guideline on clinical nutrition in liver disease.

Authors:  Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff
Journal:  Clin Nutr       Date:  2019-01-16       Impact factor: 7.324

Review 7.  Abnormalities of Lipoprotein Levels in Liver Cirrhosis: Clinical Relevance.

Authors:  Graziella Privitera; Luisa Spadaro; Simona Marchisello; Giuseppe Fede; Francesco Purrello
Journal:  Dig Dis Sci       Date:  2017-11-25       Impact factor: 3.199

8.  Nutritional status and liver transplantation.

Authors:  Manuela Merli; Michela Giusto; Valerio Giannelli; Cristina Lucidi; Oliviero Riggio
Journal:  J Clin Exp Hepatol       Date:  2012-01-02

9.  Hepatic and renal metabolism before and after portasystemic shunts in patients with cirrhosis.

Authors:  O E Owen; M A Mozzoli; F A Reichle; T H Kreulen; R S Owen; G Boden; M Polansky
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

Review 10.  Hepatology - Guidelines on Parenteral Nutrition, Chapter 16.

Authors:  M Plauth; T Schuetz
Journal:  Ger Med Sci       Date:  2009-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.